Bringing 3 Significant Events Under 1 Roof! This 2017, the 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series will co-locate 3 events; Pharmaceutical Compliance, Patient-Centered Clinical Trials, and Clinical Trials Site Selection & Quality.
From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry. Watch this space!
Global Development Head Greater China Region, Novartis, China
EVP, Clinical Research &Development, Shenzhen Chipscreen Biosciences, China
Chief Medical Officer & Board Member, Generon (Shanghai) Corporation Ltd, China
Director, Clinical Development, AstraZeneca, China
Yi (Gloria) Wang
Chief China Medical Development, United Therapeutics, China
Medical Director, Roche Molecular Information – APAC, Roche, China
Ivan Eng Kien Lau
Medical Director- Shanghai Jiajing Clinic, Chief of Family Medicine, Shanghai Jiahui International Hospital, China
Medical Director, AbbVie, China
International Marketing Partner
©2016, an Informa business